Skip to main content
. Author manuscript; available in PMC: 2009 Sep 29.
Published in final edited form as: Ann Rheum Dis. 2007 Jul 20;67(3):402–408. doi: 10.1136/ard.2007.074229

Figure 8.

Figure 8

Changes in synovial immunoglobulin synthesis after rituximab therapy. Data are shown as the percentage change in values from baseline to week 8. Data is shown for patients experiencing a 50% improvement in symptoms according to the American College of Rheumatology criteria (ACR50) or higher level of response during therapy (n=3) and for non-responders. Data represents geometric mean and 95% confidence intervals. *p<0.05.